-
Taxonomy & unit
-
us-gaap: USD/shares
-
Description
-
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
-
Summary
-
Freeline Therapeutics Holdings plc quarterly/annual Earnings Per Share, Diluted history and growth rate from Q1 2022 to Q1 2023.
- Freeline Therapeutics Holdings plc Earnings Per Share, Diluted for the quarter ending March 31, 2023 was 0.02 USD/shares.
- Freeline Therapeutics Holdings plc annual Earnings Per Share, Diluted for 2022 was -1.5 USD/shares, a 61.8% increase from 2021.
- Freeline Therapeutics Holdings plc annual Earnings Per Share, Diluted for 2021 was -3.93 USD/shares, a 42.3% increase from 2020.
Earnings Per Share, Diluted, Quarterly (USD/shares)